In univariate analysis, significant predictors of HE were hematoma morphology on CT (p = 0.009), an interval of ≤4 h from the last factor Xa inhibitor intake to the initial CT (p = 0.034), and edoxaban use (p = 0.041). The gene discussed is F10; the disease is hereditary elliptocytosis.